Joy Bindroo
Research Subjects
Joy Bindroo has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Caryn Bern
Department of Epidemiology and Biostatistics, University of California San Francisco School of Medicine , San Francisco, CA 94143
2 shared publications Khushbu Priyamvada
Bihar Technical Support Program , Patna, Bihar
2 shared publicationsAllen Hightower
Independent Consultant , Atlanta Georgia
1 shared publicationAritra Das
Independent; formerly affiliated with Bihar Technical Support Program, CARE-India Solutions for Sustainable Development
1 shared publicationAsahar Alam
Bihar Technical Support Program , Patna, Bihar
1 shared publication- Asgar Ali
Bihar Technical Support Program , Patna, Bihar
1 shared publication
Latest Publications
- 1 December 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (3) , e802-e811
High Seropositivity to rK39 and Capture of Leishmania -Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India
Background: India is transitioning to the visceral leishmaniasis (VL) post-elimination phase where robust surveillance is critical to sustaining elimination. We conducted a targeted longitudinal study combining epidemiological, serological, and entomological data in endemic villages in Bihar and Jharkhand states to assess active VL transmission levels. Methods: Our investigation was conducted in the villages of Rahar Diyara, Bihar, and Murbhanga, Jharkhand, based on spatial distribution of recently reported VL cases. Samples were collected quarterly from December 2021 to September 2022 in Rahar Diyara, and April 2022 to May 2023 in Murbhanga, to determine seroprevalence against Leishmania rK39 antigen. Sand flies were collected bi-weekly in Rahar Diyara (February to December, 2022) and Murbhanga (April to December, 2022) from different microhabitats and analyzed by qPCR targeting Leishmania kDNA. Results: rK39 Leishmania seroprevalence ranged from 20% to 30% in both villages. Murbhanga, an outbreak village, exhibited higher antibody levels in 9–23% of subjects compared with the low incidence village, Rahar Diyara (3–6%), reflecting a higher intensity of transmission in Murbhanga. Despite implementation of indoor residual spraying, Leishmania-infected sand flies were found in both villages, with 1.4% (4/285) and 1.2% (5/431) positive pools in Rahar Diyara and Murbhanga, respectively. Infected sand fly pools were collected from diverse microhabitats, predominantly from vegetation in Rahar Diyara and cattle enclosures in Murbhanga, indicative of focal and distinct patterns of transmission. Conclusions: Low-level Leishmania transmission persists in India highlighting criticality of continued surveillance. Combining epidemiological, serological, and entomological surveys improves rapid outbreak assessment and intervention, and enhances efficacy of surveillance to sustain VL elimination.
- 1 December 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (3) , e802-e811
High Seropositivity to rK39 and Capture of Leishmania -Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India
Background: India is transitioning to the visceral leishmaniasis (VL) post-elimination phase where robust surveillance is critical to sustaining elimination. We conducted a targeted longitudinal study combining epidemiological, serological, and entomological data in endemic villages in Bihar and Jharkhand states to assess active VL transmission levels. Methods: Our investigation was conducted in the villages of Rahar Diyara, Bihar, and Murbhanga, Jharkhand, based on spatial distribution of recently reported VL cases. Samples were collected quarterly from December 2021 to September 2022 in Rahar Diyara, and April 2022 to May 2023 in Murbhanga, to determine seroprevalence against Leishmania rK39 antigen. Sand flies were collected bi-weekly in Rahar Diyara (February to December, 2022) and Murbhanga (April to December, 2022) from different microhabitats and analyzed by qPCR targeting Leishmania kDNA. Results: rK39 Leishmania seroprevalence ranged from 20% to 30% in both villages. Murbhanga, an outbreak village, exhibited higher antibody levels in 9–23% of subjects compared with the low incidence village, Rahar Diyara (3–6%), reflecting a higher intensity of transmission in Murbhanga. Despite implementation of indoor residual spraying, Leishmania-infected sand flies were found in both villages, with 1.4% (4/285) and 1.2% (5/431) positive pools in Rahar Diyara and Murbhanga, respectively. Infected sand fly pools were collected from diverse microhabitats, predominantly from vegetation in Rahar Diyara and cattle enclosures in Murbhanga, indicative of focal and distinct patterns of transmission. Conclusions: Low-level Leishmania transmission persists in India highlighting criticality of continued surveillance. Combining epidemiological, serological, and entomological surveys improves rapid outbreak assessment and intervention, and enhances efficacy of surveillance to sustain VL elimination.
- Open Access
Spatial variation in delayed diagnosis of visceral leishmaniasis in Bihar, India
Background Visceral leishmaniasis (VL) is a debilitating disease and without treatment, a fatal disease which burdens the most impoverished communities in northeastern India. Control and ultimately, elimination of VL depends heavily on prompt case detection. However, a proportion of VL cases remain undiagnosed many months after symptom onset. Delay to diagnosis increases the chance of onward transmission, and poses a risk of resurgence in populations with waning immunity. We checked the spatial variation of delayed diagnosis of VL in Bihar, India and aimed to understand the potential driving factors of delayed diagnosis. Methods The spatial distribution of diagnostic delays was explored using a Bayesian model fit to geo-located cases using the Integrated Nested Laplace Approximation (INLA) approach, assuming days of delay as Poisson-distributed and adjusting for individual-(age, sex, HIV) and local-level (recent incidence, vector control, health facility access) characteristics. Residual variance was modelled with an explicit spatial structure. Cumulative delays were estimated under different scenarios of active case detection coverage. Findings The 4,270 cases analysed were prone to excessive delays outside existing endemic “hot spots”, beyond the focus of interventions. Cases diagnosed within recently-affected blocks and villages experienced shorter delays on average (by 13% 95% Credible Interval [2.9% - 21.7%] and 7% [1.3% - 13.1%], respectively) than those in non-recently-affected areas. Interpretation Delays to VL diagnosis when incidence is low could influence whether transmission of the disease could be interrupted or resurges. Prioritising and narrowing surveillance to high-burden areas may increase the likelihood of excessive delays in diagnosis in peripheral areas. Active surveillance driven by observed incidence may lead to missing the risk posed by as-yet-undiagnosed cases in low-endemic areas, and such surveillance could be insufficient for achieving and sustaining elimination. Funding The Bill and Melinda Gates Foundation.
Open AccessSpatial variation in delayed diagnosis of visceral leishmaniasis in Bihar, India
Background Visceral leishmaniasis (VL) is a debilitating disease and without treatment, a fatal disease which burdens the most impoverished communities in northeastern India. Control and ultimately, elimination of VL depends heavily on prompt case detection. However, a proportion of VL cases remain undiagnosed many months after symptom onset. Delay to diagnosis increases the chance of onward transmission, and poses a risk of resurgence in populations with waning immunity. We checked the spatial variation of delayed diagnosis of VL in Bihar, India and aimed to understand the potential driving factors of delayed diagnosis. Methods The spatial distribution of diagnostic delays was explored using a Bayesian model fit to geo-located cases using the Integrated Nested Laplace Approximation (INLA) approach, assuming days of delay as Poisson-distributed and adjusting for individual-(age, sex, HIV) and local-level (recent incidence, vector control, health facility access) characteristics. Residual variance was modelled with an explicit spatial structure. Cumulative delays were estimated under different scenarios of active case detection coverage. Findings The 4,270 cases analysed were prone to excessive delays outside existing endemic “hot spots”, beyond the focus of interventions. Cases diagnosed within recently-affected blocks and villages experienced shorter delays on average (by 13% 95% Credible Interval [2.9% - 21.7%] and 7% [1.3% - 13.1%], respectively) than those in non-recently-affected areas. Interpretation Delays to VL diagnosis when incidence is low could influence whether transmission of the disease could be interrupted or resurges. Prioritising and narrowing surveillance to high-burden areas may increase the likelihood of excessive delays in diagnosis in peripheral areas. Active surveillance driven by observed incidence may lead to missing the risk posed by as-yet-undiagnosed cases in low-endemic areas, and such surveillance could be insufficient for achieving and sustaining elimination. Funding The Bill and Melinda Gates Foundation.